Doximity, Inc. Class A Common Stock (NY:DOCS)

33.80 +0.56 (+1.68%)

Delayed Quote Updated: 2:54 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

32 33 Next >

What's going on in today's pre-market session ↗

February 07, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

Deep Dive Into Doximity Stock: Analyst Perspectives (12 Ratings) ↗

February 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 07, 2025

Via Benzinga

Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

February 07, 2025

Via Benzinga

Doximity Earnings Report: Q3 Overview ↗

February 06, 2025

Via Benzinga

Earnings Scheduled For February 6, 2025 ↗

February 06, 2025

Via Benzinga

Demystifying Doximity: Insights From 15 Analyst Reviews ↗

January 13, 2025

Via Benzinga

Looking Into Doximity's Recent Short Interest ↗

January 08, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

February 06, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

IBD 50 Stock Doximity Rockets And Eyes A Breakout After Walloping Earnings Views ↗

February 06, 2025

Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook.

Via Investor's Business Daily

Doximity Surpasses EPS, Revenue Goals ↗

February 06, 2025

Doximity exceeded expectations with strong revenue and net income growth, highlighting robust operational performance.

Via The Motley Fool

Doximity (NYSE:DOCS) Reports Upbeat Q4, Stock Jumps 22.5%

February 06, 2025

Healthcare professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 24.6% year on year to $168.6 million. On top of that, next...

Via StockStory

NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

January 06, 2025

DOXIMITY INC-CLASS A (NYSE:DOCS)—A High-Growth Stock Gearing Up for Its Next Upward Move.

Via Chartmill

Why the quality investor may take a look at DOXIMITY INC-CLASS A (NYSE:DOCS). ↗

December 24, 2024

Why DOXIMITY INC-CLASS A (NYSE:DOCS) qualifies as a quality stock.

Via Chartmill

Forecasting The Future: 15 Analyst Projections For Doximity ↗

December 20, 2024

Via Benzinga

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

February 06, 2025

From Doximity

Via Business Wire

Doximity Announces Fiscal 2025 Third Quarter Financial Results

February 06, 2025

From Doximity

Via Business Wire

Doximity (DOCS) Q4 Earnings: What To Expect

February 05, 2025

Healthcare professional network Doximity (NYSE:DOCS) will be announcing earnings results tomorrow afternoon. Here’s what you need to know.

Via StockStory

Investors seeking growth at a reasonable cost should explore NYSE:DOCS. ↗

February 03, 2025

Uncover the potential of DOXIMITY INC-CLASS A, a growth stock reasonably priced. NYSE:DOCS is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive...

Via Chartmill

Reasonable Growth, Debt Levels, and a High ROIC Make DOXIMITY INC-CLASS A (NYSE:DOCS) Appealing to Quality Investors. ↗

January 22, 2025

Why Quality-Oriented Investors Should Consider NYSE:DOCS.

Via Chartmill

(DOCS) - Analyzing Doximity's Short Interest ↗

December 20, 2024

Via Benzinga

Analyst Ratings For Doximity ↗

December 04, 2024

Via Benzinga

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

January 16, 2025

From Doximity

Via Business Wire

Spotting Winners: Doximity (NYSE:DOCS) And Vertical Software Stocks In Q3

January 14, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at vertical software stocks, starting with...

Via StockStory

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio? ↗

December 22, 2024

The top-performing stocks last week were TEVA, KVYO, DRI, DOCS, BIRK, JBL, NBIX, GME, RDY, and LI. Did you have any of them in your portfolio?

Via Benzinga

Kick-Save And A Beauty; Two New Swing Positions ↗

December 21, 2024

In this video, I review the overall market. I also provide two new swing positions, along with my exact game plan for Monday's session.

Via Talk Markets

Topics ETFs Stocks / Equities

Google Leads Five Stocks Near Buy Points, Standing Tall In Tricky Market ↗

December 21, 2024

The AI giant leads stocks near buy points as the postelection rally turns volatile.

Via Investor's Business Daily

Topics Artificial Intelligence

DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 19, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Veeva Systems Stock Sees IBD RS Rating Improve To 72 ↗

December 18, 2024

Veeva Systems stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 68 to 72.

Via Investor's Business Daily

Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care

December 17, 2024

From Doximity

Via Business Wire

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.